Yat Sun Or

2012

In 2012, Yat Sun Or earned a total compensation of $606.1K as Senior Vice President, Research Development and Chief Scientific Officer at Enanta Pharmaceuticals, a 20% increase compared to previous year.

Compensation breakdown

Bonus$136,569
Option Awards$143,704
Salary$321,415
Other$4,439
Total$606,127

Or received $321.4K in salary, accounting for 53% of the total pay in 2012.

Or also received $136.6K in bonus, $143.7K in option awards and $4.4K in other compensation.

Rankings

In 2012, Yat Sun Or's compensation ranked 8,092nd out of 11,487 executives tracked by ExecPay. In other words, Or earned more than 29.6% of executives.

ClassificationRankingPercentile
All
8,092
out of 11,487
30th
Division
Manufacturing
2,922
out of 4,252
31st
Major group
Chemicals And Allied Products
771
out of 1,200
36th
Industry group
Drugs
549
out of 922
41st
Industry
Pharmaceutical Preparations
430
out of 697
38th
Source: SEC filing on January 15, 2015.

Or's colleagues

We found two more compensation records of executives who worked with Yat Sun Or at Enanta Pharmaceuticals in 2012.

2012

Jay Luly

Enanta Pharmaceuticals

Chief Executive Officer

2012

Paul Mellett

Enanta Pharmaceuticals

Chief Financial Officer

News

You may also like